|
We conducted a clinical controlled trial of exogenous surfactant replacement therapy in premature
infants with hyaline membrane disease at the neonatal intensive care unit of Yonsei University
Medical Center form Nov. 1987 to May 1988.
Sixteen premature infants with severe HMD were randomly assigned to control group or
surfactant-treated group. Eight infants (mean gestational age 29.9±2.8 week, mean birth weight 1,
425±308.9 gm) were given... |